The Efficacy β-Alanine Supplementation in Performance Outcomes of Road Professional Endurance Cyclists

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-10

Study Completion Date

2020-06-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A double-blind, placebo-controlled, randomised, with two arms (product and placebo) unicentric clinical trial to analyse the efficacy on physical performance parameters of a product designed for sport during a lapse of two weeks (7 days).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Analyze the Aerobic Performance Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists

NCT06167395

Beta Alanine Supplementation

COMPLETED NA

Study to Analyze the Efficacy of Acute Intake With a β-alanine Supplement in Recreational Cyclists

NCT06180512

Beta Alanine Supplementation

COMPLETED NA

Safety Analysis of Chronic Intake of a β-alanine Supplement

NCT05334121

Product Safety

COMPLETED NA

24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males

NCT03655041

Sports Nutritional Physiological Phenomena

COMPLETED NA

Acute Supplementation With Beta-Alanine Improves Performance in Aerobic-anaerobic Transition Zones in Endurance Athletes

NCT05096793

Beta-alanine

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After recruitment, subject will be randomised and allocated to one group of the 2 study arms: treatment group or control group (placebo).

A simple randomisation will be performed using software by a random number generator, and assigned to participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Supplementation Cyclists

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Product: β-Alanine Supplementation strategy: 5 g, four times a day with main meals, for 7 days after the initial evaluation and until the end of the study.

Group Type EXPERIMENTAL

β-alanine

Intervention Type DIETARY_SUPPLEMENT

7 days of consumption

Placebo group

Product: wheat semolina Supplementation strategy: 5 g, four times a day with main meals, for 7 days after the initial evaluation and until the end of the study.

Group Type PLACEBO_COMPARATOR

wheat semolina

Intervention Type DIETARY_SUPPLEMENT

7 days of consumption

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

β-alanine

7 days of consumption

Intervention Type DIETARY_SUPPLEMENT

wheat semolina

7 days of consumption

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Not respecting rest the day before physical tests.
* Not being in a fasted state (at least 2 h from last meal).
* Having consumed stimulants acutely before the trial, or under drug treatment affecting perceived effort of the trial.
* Not being available to perform every trial on the same conditions at the same time of the day.
* Not sticking to the same diet, 24 h before each trial.

Exclusion Criteria

* Adverse event
* Protocol violation
* Lost to follow-up
* Allergy to any of the components of the treatment or placebo product. This includes allergy to β-alanine, wheat, soy, nuts (including peanuts), sesame and its byproducts.

Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes